O	O	O	0	11	Leukotriene	Leukotriene	B-NP	NN	O	2	NMOD	O
O	O	O	12	14	B4	B4	I-NP	NN	O	3	SUB	O
O	O	O	15	25	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	O
T1	B-Protein	B-Protein	26	27	c	c	B-NP	NN	B-DNA	6	NMOD	B-DNA
T1	I-Protein	I-Protein	27	28	-	-	I-NP	HYPH	I-DNA	6	NMOD	I-DNA
T1	I-Protein	I-Protein	28	31	fos	fos	I-NP	NN	I-DNA	18	NMOD	I-DNA
O	O	O	32	35	and	and	I-NP	CC	O	18	NMOD	O
T2	B-Protein	B-Protein	36	37	c	c	I-NP	NN	O	18	NMOD	O
T2	I-Protein	I-Protein	37	38	-	-	O	HYPH	O	18	NMOD	O
T2	I-Protein	I-Protein	38	41	jun	jun	B-NP	NN	B-DNA	11	NMOD	B-DNA
O	O	O	42	46	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	47	60	transcription	transcription	I-NP	NN	O	18	NMOD	O
O	O	O	61	64	and	and	I-NP	CC	O	18	NMOD	O
T14	B-Entity	B-Entity	65	67	AP	AP	I-NP	NN	B-protein	18	NMOD	B-protein
T14	I-Entity	I-Entity	67	68	-	-	B-NP	HYPH	I-protein	18	NMOD	I-protein
T14	I-Entity	I-Entity	68	69	1	1	I-NP	CD	I-protein	18	NMOD	I-protein
O	O	O	70	77	binding	binding	I-NP	NN	O	18	NMOD	O
O	O	O	78	86	activity	activity	I-NP	NN	O	3	OBJ	O
O	O	O	87	89	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	90	95	human	human	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	O	96	105	monocytes	monocyte	I-NP	NNS	I-cell_type	19	PMOD	I-cell_type
O	O	O	105	106	.	.	O	.	O	3	P	O

O	O	O	108	110	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	111	115	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	116	124	examined	examine	I-VP	VBN	O	2	VC	O
O	O	O	125	128	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	129	135	effect	effect	I-NP	NN	O	3	OBJ	O
O	O	O	136	138	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	139	150	leukotriene	leukotriene	B-NP	NN	O	8	NMOD	O
O	O	O	151	153	B4	B4	I-NP	NN	O	17	NMOD	O
O	O	O	154	155	(	(	O	(	O	11	DEP	O
O	O	O	155	159	LTB4	LTB4	B-NP	NN	B-protein	11	DEP	B-protein
O	O	O	159	160	)	)	O	)	O	8	NMOD	O
O	O	O	160	161	,	,	O	,	O	17	P	O
O	O	O	162	163	a	a	B-NP	DT	O	17	NMOD	O
O	O	O	164	170	potent	potent	I-NP	JJ	O	17	NMOD	O
O	O	O	171	176	lipid	lipid	I-NP	NN	O	17	NMOD	O
O	O	O	177	192	proinflammatory	proinflammatory	I-NP	JJ	B-protein	17	NMOD	B-protein
O	O	O	193	201	mediator	mediator	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	O	201	202	,	,	O	,	O	17	P	O
O	O	O	203	205	on	on	B-PP	IN	O	5	NMOD	O
O	O	O	206	209	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	210	220	expression	expression	I-NP	NN	O	19	PMOD	O
O	O	O	221	223	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	224	227	the	the	B-NP	DT	O	33	NMOD	O
T15	B-Entity	B-Entity	228	233	proto	proto	I-NP	AFX	B-DNA	33	NMOD	B-DNA
T15	I-Entity	I-Entity	233	234	-	-	I-NP	HYPH	I-DNA	33	NMOD	I-DNA
T15	I-Entity	I-Entity	234	243	oncogenes	oncogene	I-NP	NNS	I-DNA	33	NMOD	I-DNA
T3	B-Protein	B-Protein	244	245	c	c	I-NP	NN	O	33	NMOD	O
T3	I-Protein	I-Protein	245	246	-	-	O	HYPH	O	33	P	O
T3	I-Protein	I-Protein	246	249	jun	jun	B-NP	NN	O	33	NMOD	O
O	O	O	250	253	and	and	I-NP	CC	O	33	NMOD	O
T4	B-Protein	B-Protein	254	255	c	c	I-NP	NN	O	33	NMOD	O
T4	I-Protein	I-Protein	255	256	-	-	B-NP	HYPH	O	33	NMOD	O
T4	I-Protein	I-Protein	256	259	fos	fos	I-NP	NN	O	22	PMOD	O
O	O	O	259	260	.	.	O	.	O	2	P	O

O	O	O	261	263	In	In	B-PP	IN	O	5	VMOD	O
O	O	O	264	272	addition	addition	B-NP	NN	O	1	PMOD	O
O	O	O	272	273	,	,	O	,	O	5	P	O
O	O	O	274	276	we	we	B-NP	PRP	O	5	SUB	O
O	O	O	277	283	looked	look	B-VP	VBD	O	0	ROOT	O
O	O	O	284	286	at	at	B-PP	IN	O	5	VMOD	O
O	O	O	287	290	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	291	301	modulation	modulation	I-NP	NN	O	6	PMOD	O
O	O	O	302	304	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	305	312	nuclear	nuclear	B-NP	JJ	B-protein	11	NMOD	B-protein
O	O	O	313	320	factors	factor	I-NP	NNS	I-protein	9	PMOD	I-protein
O	O	O	321	328	binding	bind	B-VP	VBG	O	11	NMOD	O
O	O	O	329	341	specifically	specifically	B-ADVP	RB	O	14	PMOD	O
O	O	O	342	344	to	to	B-PP	TO	O	12	VMOD	O
O	O	O	345	348	the	the	B-NP	DT	O	19	NMOD	O
T16,T17	B-Entity,B-Entity	B-Entity,B-Entity	349	351	AP	AP	I-NP	NN	B-DNA	19	NMOD	B-DNA
T16	I-Entity	I-Entity	351	352	-	-	B-NP	HYPH	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	352	353	1	1	I-NP	CD	I-DNA	19	NMOD	I-DNA
T16	I-Entity	I-Entity	354	361	element	element	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	362	367	after	after	B-PP	IN	O	19	NMOD	O
O	O	O	368	372	LTB4	LTB4	B-NP	NN	O	22	NMOD	O
O	O	O	373	384	stimulation	stimulation	I-NP	NN	O	20	PMOD	O
O	O	O	384	385	.	.	O	.	O	5	P	O

O	O	O	386	390	LTB4	LTB4	B-NP	NN	O	2	SUB	O
O	O	O	391	400	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	O	401	404	the	the	B-NP	DT	O	4	NMOD	O
O	O	O	405	415	expression	expression	I-NP	NN	O	2	OBJ	O
O	O	O	416	418	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	419	422	the	the	B-NP	DT	O	10	NMOD	O
T5	B-Protein	B-Protein	423	424	c	c	I-NP	NN	B-DNA	10	NMOD	B-DNA
T5	I-Protein	I-Protein	424	425	-	-	B-NP	HYPH	I-DNA	10	NMOD	I-DNA
T5	I-Protein	I-Protein	425	428	fos	fos	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	429	433	gene	gene	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	O	434	436	in	in	B-PP	IN	O	2	VMOD	O
O	O	O	437	438	a	a	B-NP	DT	O	19	NMOD	O
O	O	O	439	443	time	time	I-NP	NN	O	19	NMOD	O
O	O	O	443	444	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	O	445	448	and	and	I-NP	CC	O	19	NMOD	O
O	O	O	449	462	concentration	concentration	I-NP	NN	O	19	NMOD	O
O	O	O	462	463	-	-	I-NP	HYPH	O	19	NMOD	O
O	O	O	463	472	dependent	dependent	I-NP	JJ	O	19	NMOD	O
O	O	O	473	479	manner	manner	I-NP	NN	O	11	PMOD	O
O	O	O	479	480	.	.	O	.	O	2	P	O

O	O	O	481	484	The	The	B-NP	DT	O	5	NMOD	O
T6	B-Protein	B-Protein	485	486	c	c	I-NP	NN	B-RNA	5	NMOD	B-RNA
T6	I-Protein	I-Protein	486	487	-	-	O	HYPH	I-RNA	5	NMOD	I-RNA
T6	I-Protein	I-Protein	487	490	jun	jun	B-NP	NN	I-RNA	5	NMOD	I-RNA
O	O	O	491	495	mRNA	mRNA	I-NP	NN	I-RNA	22	SUB	I-RNA
O	O	O	495	496	,	,	O	,	O	5	P	O
O	O	O	497	502	which	which	B-NP	WDT	O	5	NMOD	O
O	O	O	503	505	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	O	506	520	constitutively	constitutively	I-VP	RB	O	8	VMOD	O
O	O	O	521	530	expressed	express	I-VP	VBN	O	8	VC	O
O	O	O	531	533	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	534	539	human	human	B-NP	JJ	O	11	PMOD	O
O	O	O	540	550	peripheral	peripheral	I-NP	JJ	O	16	NMOD	O
O	O	O	550	551	-	-	I-NP	HYPH	O	16	NMOD	O
O	O	O	551	556	blood	blood	I-NP	NN	B-cell_type	16	NMOD	B-cell_type
O	O	O	557	566	monocytes	monocyte	I-NP	NNS	I-cell_type	12	NMOD	I-cell_type
O	O	O	567	569	at	at	B-PP	IN	O	10	VMOD	O
O	O	O	570	580	relatively	relatively	B-NP	RB	O	19	AMOD	O
O	O	O	581	585	high	high	I-NP	JJ	O	20	NMOD	O
O	O	O	586	592	levels	level	I-NP	NNS	O	17	PMOD	O
O	O	O	592	593	,	,	O	,	O	5	P	O
O	O	O	594	597	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	598	602	also	also	I-VP	RB	O	22	VMOD	O
O	O	O	603	611	slightly	slightly	I-VP	RB	O	22	VMOD	O
O	O	O	612	621	augmented	augment	I-VP	VBN	O	22	VC	O
O	O	O	622	624	by	by	B-PP	IN	O	25	VMOD	O
O	O	O	625	629	LTB4	LTB4	B-NP	NN	O	26	PMOD	O
O	O	O	629	630	,	,	O	,	O	25	P	O
O	O	O	631	639	although	although	B-SBAR	IN	O	25	VMOD	O
O	O	O	640	642	to	to	B-PP	TO	O	29	DEP	O
O	O	O	643	644	a	a	B-NP	DT	O	34	NMOD	O
O	O	O	645	649	much	much	I-NP	RB	O	33	AMOD	O
O	O	O	650	655	lower	low	I-NP	JJR	O	34	NMOD	O
O	O	O	656	662	extent	extent	I-NP	NN	O	30	PMOD	O
O	O	O	663	667	than	than	B-PP	IN	O	34	NMOD	O
T7	B-Protein	B-Protein	668	669	c	c	B-NP	NN	B-DNA	38	NMOD	B-DNA
T7	I-Protein	I-Protein	669	670	-	-	I-NP	HYPH	I-DNA	38	NMOD	I-DNA
T7	I-Protein	I-Protein	670	673	fos	fos	I-NP	NN	I-DNA	35	PMOD	I-DNA
O	O	O	673	674	.	.	O	.	O	22	P	O

O	O	O	675	678	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	679	687	kinetics	kinetic	I-NP	NNS	O	9	SUB	O
O	O	O	688	690	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	691	701	expression	expression	B-NP	NN	O	3	PMOD	O
O	O	O	702	704	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	705	708	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	709	712	two	two	I-NP	CD	O	8	NMOD	O
O	O	O	713	718	genes	gene	I-NP	NNS	O	5	PMOD	O
O	O	O	719	723	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	724	728	also	also	B-ADVP	RB	O	9	VMOD	O
O	O	O	729	737	slightly	slightly	B-ADJP	RB	O	12	AMOD	O
O	O	O	738	747	different	different	I-ADJP	JJ	O	9	PRD	O
O	O	O	747	748	,	,	O	,	O	9	P	O
O	O	O	749	753	with	with	B-PP	IN	O	9	VMOD	O
T8	B-Protein	B-Protein	754	755	c	c	B-NP	NN	B-RNA	18	NMOD	B-RNA
T8	I-Protein	I-Protein	755	756	-	-	O	HYPH	I-RNA	18	NMOD	I-RNA
T8	I-Protein	I-Protein	756	759	fos	fos	B-NP	NN	I-RNA	18	NMOD	I-RNA
O	O	O	760	764	mRNA	mRNA	I-NP	NN	I-RNA	14	PMOD	I-RNA
O	O	O	765	773	reaching	reach	B-VP	VBG	O	18	NMOD	O
O	O	O	774	775	a	a	B-NP	DT	O	21	NMOD	O
O	O	O	776	780	peak	peak	I-NP	NN	O	19	OBJ	O
O	O	O	781	783	at	at	B-PP	IN	O	19	VMOD	O
O	O	O	784	786	15	15	B-NP	CD	O	24	NMOD	O
O	O	O	787	790	min	min	I-NP	NN	O	22	PMOD	O
O	O	O	791	796	after	after	B-PP	IN	O	24	NMOD	O
O	O	O	797	808	stimulation	stimulation	B-NP	NN	O	30	NMOD	O
O	O	O	809	812	and	and	I-NP	CC	O	30	NMOD	O
T9	B-Protein	B-Protein	813	814	c	c	I-NP	NN	B-DNA	30	NMOD	B-DNA
T9	I-Protein	I-Protein	814	815	-	-	O	HYPH	I-DNA	30	P	I-DNA
T9	I-Protein	I-Protein	815	818	jun	jun	B-NP	NN	I-DNA	25	PMOD	I-DNA
O	O	O	819	821	at	at	B-PP	IN	O	9	VMOD	O
O	O	O	822	824	30	30	B-NP	CD	O	33	NMOD	O
O	O	O	825	828	min	min	I-NP	NN	O	31	PMOD	O
O	O	O	828	829	.	.	O	.	O	9	P	O

O	O	O	830	834	Both	Both	B-NP	DT	O	2	NMOD	O
O	O	O	835	843	messages	message	I-NP	NNS	O	4	SUB	O
O	O	O	844	851	rapidly	rapidly	B-ADVP	RB	O	4	VMOD	O
O	O	O	852	860	declined	decline	B-VP	VBD	O	0	ROOT	O
O	O	O	861	871	thereafter	thereafter	B-ADVP	RB	O	4	VMOD	O
O	O	O	871	872	.	.	O	.	O	4	P	O

O	O	O	873	882	Stability	Stability	B-NP	NN	O	12	SUB	O
O	O	O	883	885	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	886	889	the	the	B-NP	DT	O	6	NMOD	O
T10	B-Protein	B-Protein	890	891	c	c	I-NP	NN	B-DNA	6	NMOD	B-DNA
T10	I-Protein	I-Protein	891	892	-	-	B-NP	HYPH	I-DNA	6	NMOD	I-DNA
T10	I-Protein	I-Protein	892	895	fos	fos	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	O	896	899	and	and	I-NP	CC	O	11	NMOD	O
T11	B-Protein	B-Protein	900	901	c	c	I-NP	NN	O	11	NMOD	O
T11	I-Protein	I-Protein	901	902	-	-	O	HYPH	O	11	NMOD	O
T11	I-Protein	I-Protein	902	905	jun	jun	B-NP	NN	B-RNA	11	NMOD	B-RNA
O	O	O	906	910	mRNA	mRNA	I-NP	NN	I-RNA	2	PMOD	I-RNA
O	O	O	911	914	was	be	B-VP	VBD	O	0	ROOT	O
O	O	O	915	918	not	not	I-VP	RB	O	12	VMOD	O
O	O	O	919	927	affected	affect	I-VP	VBN	O	12	VC	O
O	O	O	928	930	by	by	B-PP	IN	O	14	VMOD	O
O	O	O	931	935	LTB4	LTB4	B-NP	NN	O	15	PMOD	O
O	O	O	935	936	,	,	O	,	O	14	P	O
O	O	O	937	939	as	as	B-SBAR	IN	O	14	VMOD	O
O	O	O	940	948	assessed	assess	B-VP	VBN	O	18	SBAR	O
O	O	O	949	954	after	after	B-PP	IN	O	19	VMOD	O
O	O	O	955	966	actinomycin	actinomycin	B-NP	NN	O	23	NMOD	O
O	O	O	967	968	D	D	I-NP	NN	O	23	NMOD	O
O	O	O	969	978	treatment	treatment	I-NP	NN	O	20	PMOD	O
O	O	O	978	979	.	.	O	.	O	12	P	O

O	O	O	980	987	Nuclear	Nuclear	B-NP	JJ	O	3	NMOD	O
O	O	O	988	1001	transcription	transcription	I-NP	NN	O	3	NMOD	O
O	O	O	1002	1009	studies	study	I-NP	NNS	O	6	SUB	O
O	O	O	1010	1012	in	in	B-ADVP	FW	O	3	NMOD	O
O	O	O	1013	1018	vitro	vitro	I-ADVP	FW	O	4	AMOD	O
O	O	O	1019	1025	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	O	1026	1030	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	O	1031	1035	LTB4	LTB4	B-NP	NN	O	9	SUB	O
O	O	O	1036	1045	increased	increase	B-VP	VBD	O	7	SBAR	O
O	O	O	1046	1049	the	the	B-NP	DT	O	11	NMOD	O
O	O	O	1050	1063	transcription	transcription	I-NP	NN	O	9	OBJ	O
O	O	O	1064	1066	of	of	B-PP	IN	O	11	NMOD	O
O	O	O	1067	1070	the	the	B-NP	DT	O	17	NMOD	O
T12	B-Protein	B-Protein	1071	1072	c	c	I-NP	NN	B-DNA	17	NMOD	B-DNA
T12	I-Protein	I-Protein	1072	1073	-	-	B-NP	HYPH	I-DNA	17	NMOD	I-DNA
T12	I-Protein	I-Protein	1073	1076	fos	fos	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	O	1077	1081	gene	gene	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	1082	1083	7	7	I-NP	CD	I-DNA	17	NMOD	I-DNA
O	O	O	1083	1084	-	-	O	HYPH	O	9	VMOD	O
O	O	O	1084	1088	fold	fold	B-ADVP	RB	O	19	VMOD	O
O	O	O	1089	1092	and	and	O	CC	O	20	PMOD	O
O	O	O	1093	1096	the	the	B-NP	DT	O	21	DEP	O
T13	B-Protein	B-Protein	1097	1098	c	c	I-NP	NN	O	22	DEP	O
T13	I-Protein	I-Protein	1098	1099	-	-	O	HYPH	O	23	NMOD	O
T13	I-Protein	I-Protein	1099	1102	jun	jun	B-NP	NN	B-DNA	26	NMOD	B-DNA
O	O	O	1103	1107	gene	gene	I-NP	NN	I-DNA	24	PMOD	I-DNA
O	O	O	1108	1109	1	1	I-NP	CD	I-DNA	26	NMOD	I-DNA
O	O	O	1109	1110	.	.	I-NP	.	O	26	P	O
O	O	O	1110	1111	4	4	I-NP	CD	O	26	NMOD	O
O	O	O	1111	1112	-	-	B-VP	HYPH	O	26	P	O
O	O	O	1112	1116	fold	fold	B-ADVP	RB	O	26	NMOD	O
O	O	O	1116	1117	.	.	O	.	O	6	P	O

O	O	O	1118	1125	Resting	Rest	B-NP	VBG	B-cell_type	2	NMOD	B-cell_type
O	O	O	1126	1135	monocytes	monocyte	I-NP	NNS	I-cell_type	3	SUB	I-cell_type
O	O	O	1136	1145	contained	contain	B-VP	VBD	O	20	VMOD	O
O	O	O	1146	1153	nuclear	nuclear	B-NP	JJ	B-protein	5	NMOD	B-protein
O	O	O	1154	1161	factors	factor	I-NP	NNS	I-protein	3	OBJ	I-protein
O	O	O	1162	1169	binding	bind	B-VP	VBG	O	5	NMOD	O
O	O	O	1170	1172	to	to	B-PP	TO	O	6	VMOD	O
O	O	O	1173	1176	the	the	B-NP	DT	O	12	NMOD	O
T18,T19	B-Entity,B-Entity	B-Entity,B-Entity	1177	1179	AP	AP	I-NP	NN	B-DNA	12	NMOD	B-DNA
T18	I-Entity	I-Entity	1179	1180	-	-	B-NP	HYPH	I-DNA	12	NMOD	I-DNA
T18	I-Entity	I-Entity	1180	1181	1	1	I-NP	CD	I-DNA	12	NMOD	I-DNA
T18	I-Entity	I-Entity	1182	1189	element	element	I-NP	NN	I-DNA	7	PMOD	I-DNA
O	O	O	1189	1190	,	,	O	,	O	20	P	O
O	O	O	1191	1194	but	but	O	CC	O	20	VMOD	O
O	O	O	1195	1206	stimulation	stimulation	B-NP	NN	O	20	SUB	O
O	O	O	1207	1209	of	of	B-PP	IN	O	15	NMOD	O
O	O	O	1210	1219	monocytes	monocyte	B-NP	NNS	B-cell_type	16	PMOD	B-cell_type
O	O	O	1220	1224	with	with	B-PP	IN	O	15	NMOD	O
O	O	O	1225	1229	LTB4	LTB4	B-NP	NN	O	18	PMOD	O
O	O	O	1230	1237	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	O	1238	1245	greater	great	B-NP	JJR	O	27	NMOD	O
T20	B-Entity	B-Entity	1246	1248	AP	AP	I-NP	NN	B-protein	24	SUB	B-protein
T20	I-Entity	I-Entity	1248	1249	-	-	B-NP	HYPH	I-protein	24	P	I-protein
T20	I-Entity	I-Entity	1249	1250	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	O	1250	1251	-	-	I-NP	HYPH	O	27	NMOD	O
O	O	O	1251	1258	binding	binding	I-NP	NN	O	27	NMOD	O
O	O	O	1259	1267	activity	activity	I-NP	NN	O	20	OBJ	O
O	O	O	1268	1270	of	of	B-PP	IN	O	27	NMOD	O
O	O	O	1271	1278	nuclear	nuclear	B-NP	JJ	B-protein	30	NMOD	B-protein
O	O	O	1279	1287	proteins	protein	I-NP	NNS	I-protein	28	PMOD	I-protein
O	O	O	1287	1288	.	.	O	.	O	20	P	O

O	O	O	1289	1294	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1295	1302	results	result	I-NP	NNS	O	3	SUB	O
O	O	O	1303	1311	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	O	1312	1316	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	1317	1321	LTB4	LTB4	B-NP	NN	O	6	SUB	O
O	O	O	1322	1325	may	may	B-VP	MD	O	4	SBAR	O
O	O	O	1326	1334	regulate	regulate	I-VP	VB	O	6	VC	O
O	O	O	1335	1338	the	the	B-NP	DT	O	9	NMOD	O
O	O	O	1339	1349	production	production	I-NP	NN	O	7	OBJ	O
O	O	O	1350	1352	of	of	B-PP	IN	O	9	NMOD	O
O	O	O	1353	1362	different	different	B-NP	JJ	O	10	PMOD	O
O	O	O	1363	1372	cytokines	cytokine	I-NP	NNS	B-protein	11	NMOD	B-protein
O	O	O	1373	1375	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1376	1386	modulating	modulate	B-VP	VBG	O	13	PMOD	O
O	O	O	1387	1390	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1391	1396	yield	yield	I-NP	NN	O	21	NMOD	O
O	O	O	1397	1400	and	and	O	CC	O	18	NMOD	O
O	O	O	1400	1401	/	/	B-NP	SYM	O	21	NMOD	O
O	O	O	1401	1403	or	or	O	CC	O	21	NMOD	O
O	O	O	1404	1407	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	1408	1416	function	function	I-NP	NN	O	14	OBJ	O
O	O	O	1417	1419	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	1420	1433	transcription	transcription	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	O	1434	1441	factors	factor	I-NP	NNS	I-protein	22	PMOD	I-protein
O	O	O	1442	1446	such	such	B-PP	JJ	O	26	PMOD	O
O	O	O	1447	1449	as	as	I-PP	IN	O	24	NMOD	O
T21	B-Entity	B-Entity	1450	1452	AP	AP	B-NP	NN	B-protein	28	NMOD	B-protein
T21	I-Entity	I-Entity	1452	1453	-	-	B-NP	HYPH	I-protein	26	PMOD	I-protein
T21	I-Entity	I-Entity	1453	1454	1	1	I-NP	CD	I-protein	28	NMOD	I-protein
O	O	O	1454	1455	-	-	O	HYPH	O	28	P	O
O	O	O	1455	1462	binding	bind	B-VP	VBG	O	28	NMOD	O
O	O	O	1463	1468	proto	proto	B-NP	AFX	B-protein	35	NMOD	B-protein
O	O	O	1468	1469	-	-	I-NP	HYPH	I-protein	35	NMOD	I-protein
O	O	O	1469	1477	oncogene	oncogene	I-NP	NN	I-protein	35	NMOD	I-protein
O	O	O	1478	1486	products	product	I-NP	NNS	I-protein	31	OBJ	I-protein
O	O	O	1486	1487	.	.	O	.	O	3	P	O
